Doctor profile · Federal record
Dr. Brendan Camp
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · New York, NY
- NPI 1295993996
- Accepts Medicare
- MIPS 68.5 / 100 · 2023
- 19 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
820 2Nd Ave Rm 3A
New York, NY 100174534
(212) 661-3376
Credentials & registration
- NPI registered
- May 2008 — 18 yrs on file
- Profile last updated
- January 21, 2020
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- New York #249200 · Virginia #0101252636
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1295993996. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,851
Distinct HCPCS
10
Medicare allowed
$322,836
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,228 | 231 | $8 | |
11102 |
Biopsy of related skin growth, first growth | 490 | 379 | $112 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 486 | 340 | $146 | |
17000 |
Destruction of precancer skin growth, 1 growth | 453 | 310 | $55 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 433 | 316 | $103 | |
17110 |
Destruction of skin growth, 1-14 growths | 158 | 134 | $130 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 134 | 134 | $192 | |
11103 |
Biopsy of related skin growth, each additional growth | 132 | 96 | $58 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 65 | 58 | $204 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 56 | 56 | $125 |
In context: peer comparison
Among 139 peers in New York Dermatology Physician, average services per provider: 182. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$2,059
Transactions
102
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 18 | $383.64 | |
| Janssen Biotech, INC. | 12 | $288.00 | |
| Lilly USA, LLC | 13 | $236.83 | |
| Novartis Pharmaceuticals Corporation | 13 | $224.84 | |
| Dermavant Sciences, INC. | 11 | $178.89 | |
| Arcutis Biotherapeutics, INC. | 5 | $101.55 | |
| Pfizer INC. | 4 | $93.03 | |
| Amgen INC. | 5 | $89.53 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $85.57 | |
| Incyte Corporation | 4 | $81.82 | |
| Leo Pharma INC. | 4 | $77.37 | |
| Galderma Laboratories, L.P. | 3 | $68.07 | |
| Ucb, INC. | 3 | $51.96 | |
| Helsinn Therapeutics (U.S.), INC. | 2 | $47.88 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $18.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
617
Patients
349
Total drug cost
$16,947
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 129 | 88 | $1,047 |
| Mupirocin | Generic | 92 | 68 | $860 |
| Ketoconazole | Generic | 85 | 46 | $2,096 |
| Betamethasone Dipropionate | Generic | 54 | 34 | $2,967 |
| Hydrocortisone | Generic | 50 | 32 | $296 |
| Clobetasol Propionate | Generic | 37 | 15 | $2,818 |
| Metronidazole | Generic | 32 | 22 | $2,108 |
| Fluocinonide | Generic | 24 | 19 | $1,240 |
| Clindamycin Phosphate | Generic | 22 | 0 | $989 |
| Nystatin | Generic | 20 | 12 | $146 |
Frequently asked questions
What is Dr. Brendan Camp's medical specialty?
Dr. Brendan Camp practices Dermatology Physician in New York, NY.
Where does Dr. Brendan Camp practice?
Dr. Brendan Camp practices at 820 2Nd Ave Rm 3A, New York, NY 100174534. Office phone: 2126613376.
What is Dr. Brendan Camp's NPI?
Dr. Brendan Camp's National Provider Identifier (NPI) is 1295993996, issued by NPPES.
Does Dr. Brendan Camp accept Medicare assignment?
Yes. Dr. Brendan Camp accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Brendan Camp commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.